Enhancing Studies on a Possible Blood Biomarker for TBI (IMAGE)

NYU Langone Health / NYU Grossman School of Medicine

Enhancing Studies on a Possible Blood Biomarker for TBI

Caption

The single molecule array (Simoa) technology developed by Quanterix, and the fully automated HD-1 analyzer, offers unprecedented improvement in sensitivity proteins over current technologies for the detection of blood-based biomarkers -- as much as 1000 times more sensitive than conventional immunoassays

Credit

Photo Courtesy of Quanterix, Inc.

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.